WallStSmart
GOVX

GeoVax Labs Inc

NASDAQ: GOVX · HEALTHCARE · BIOTECHNOLOGY

$1.05
-4.55% today

Updated 2026-04-29

Market cap
$3.21M
P/E ratio
P/S ratio
1.29x
EPS (TTM)
$-22.40
Dividend yield
52W range
$1 – $35
Volume
0.1M

GeoVax Labs Inc (GOVX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-1.33M$-3.27M$-2.37M$-1.43M$-2.01M$-303621.00$-2.44M$-1.69M$-2.25M$-2.71M$-1.95M$-1.69M$-1.54M$-1.40M$-2.75M$-11.20M$-19.03M$-25.17M$-24.68M$-21.47M
Capital expenditures$69466.00$0.00$99831.00$270246.00$4706.00$11896.00$0.00$86603.00$35503.00$15850.00$15.85M$4350.00$7606.00$7603.00$156791.00$47718.00$134258.00$48946.00$20653.00$27612.00
Depreciation
Stock-based comp$2.02M$1.30M$750532.00$772997.00$310076.00$402104.00$479103.00$67905.00$967667.00$57224.00$469724.00$327500.00$64463.00$369987.00$902074.00$1.07M$528644.00$1.12M
Free cash flow$-1.40M$-3.27M$-2.47M$-1.70M$-2.01M$-315517.00$-2.44M$-1.78M$-2.29M$-2.72M$-17.80M$-1.69M$-1.55M$-1.41M$-2.91M$-11.24M$-19.16M$-25.22M$-24.70M$-21.50M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash$9.60M